Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Change in Cash (2016 - 2025)

Historic Change in Cash for SRx Health Solutions (SRXH) over the last 15 years, with Q2 2025 value amounting to $690000.0.

  • SRx Health Solutions' Change in Cash rose 201666.67% to $690000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $816000.0, marking a year-over-year increase of 25021.46%. This contributed to the annual value of -$5.0 million for FY2023, which is 7422.57% up from last year.
  • Per SRx Health Solutions' latest filing, its Change in Cash stood at $690000.0 for Q2 2025, which was up 201666.67% from -$1.9 million recorded in Q1 2025.
  • In the past 5 years, SRx Health Solutions' Change in Cash ranged from a high of $30.7 million in Q3 2021 and a low of -$5.6 million during Q2 2022
  • Its 5-year average for Change in Cash is $37055.6, with a median of -$1.1 million in 2023.
  • As far as peak fluctuations go, SRx Health Solutions' Change in Cash surged by 228449.5% in 2021, and later crashed by 158494.62% in 2022.
  • Quarter analysis of 5 years shows SRx Health Solutions' Change in Cash stood at -$4.3 million in 2021, then grew by 27.25% to -$3.1 million in 2022, then soared by 120.85% to $655000.0 in 2023, then dropped by 7.63% to $605000.0 in 2024, then rose by 14.05% to $690000.0 in 2025.
  • Its Change in Cash was $690000.0 in Q2 2025, compared to -$1.9 million in Q1 2025 and $605000.0 in Q4 2024.